Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
抗FcRH5抗体药物偶联物DFRF4539A治疗复发或难治性多发性骨髓瘤的I期研究
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-019-0178-8
Stewart, A Keith; Krishnan, Amrita Y; Singhal, Seema; Boccia, Ralph V; Patel, Manish R; Niesvizky, Ruben; Chanan-Khan, Asher A; Ailawadhi, Sikander; Brumm, Jochen; Mundt, Kirsten E; Hong, Kyu; McBride, Jacqueline; Shon-Nguyen, Quyen; Xiao, Yuanyuan; Ramakrishnan, Vanitha; Polson, Andrew G; Samineni, Divya; Leipold, Douglas; Humke, Eric W; McClellan, James Scott; Berdeja, Jesus G
